Regarding the choice of therapy with anti-IL-5, the often proposed differentiation between non-allergic patients with nasal polyps and elevated blood eosinophils and patients allergic to anti-IgE is not supported by evidence. The gene discussed is IGHE; the disease is nasal cavity polyp.